Currently, out of the existing stock ratings of Gregory Fraser - 27 which are a Buy (81.82%), 6 which are a Hold (18.18%)

Gregory Fraser

Work Performance Price Targets & Ratings Chart

Analyst Gregory Fraser works at TRUIST and is covering the Healthcare sector with 85 price targets and ratings displayed on 11 stocks.

Gregory Fraser's average stock forecast success ratio is 41.67% with an average time for price targets to be met of 128.73 days.

Most recent stock forecast was given on ANIP, ANI Pharmaceuticals at 21-Aug-2023.

Wall Street Analyst Gregory Fraser

Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 2/24/2021. The price target of $12 was fulfilled within 2 days with a profit of $0.54 (4.71%) receiving and performance score of 23.56.

Average potential price target upside

CRXT OSMT Osmotica Pharmaceuticals plc BDSI BioDelivery Sciences International NVCR NovoCure ANIP ANI Pharmaceuticals CORT Corcept Therapeutics EOLS Evolus XAIR BHC Bausch Health Companies AERI Aerie Pharmaceuticals RVLP

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

12

1 years 29 days ago

0/1 (0%)

$8.18 (214.14%)

Buy

13

1 years 30 days ago

0/1 (0%)

$8.7 (202.33%)

Buy

12

1 years 5 months 10 days ago

0/1 (0%)

$3.91 (48.33%)

Buy

20

1 years 5 months 10 days ago

0/1 (0%)

$11.91 (147.22%)

Buy

10

$9.98 (49900.00%)

1 years 11 months 7 days ago

0/1 (0%)

$4.78 (91.57%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Gregory Fraser is most bullish on?

Potential upside of $77.22 has been obtained for NVCR (NOVOCURE)

Which stock is Gregory Fraser is most reserved on?

Potential downside of -$3.04 has been obtained for CORT (CORCEPT THERAPEUTICS)

What Year was the first public recommendation made by Gregory Fraser?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart